#1 Clinical Trials Search in Europe

Study of the distribution of cefazolin in the chest area of children undergoing heart surgery to prevent infection.

1 1 1 1

What is this study about?

This study aims to describe how the antibiotic cefazolin moves through the mediastinum, which is the area in the middle of the chest between the lungs, in children after heart surgery. The research focuses on infection prophylaxis, which is a way to prevent infections from occurring before they start. During the study, cefazolin is given through intravenous administration, meaning it is delivered directly into a vein.

The process involves using microdialysis, a method used to monitor the levels of a substance in the body’s tissues. Participants will have their levels monitored to see how the medication travels from the blood into the chest area. Researchers will also monitor signs of inflammation, such as CRP, which is a protein in the blood that increases when there is irritation or infection in the body, and watch for any signs of mediastinitis, an infection in the middle of the chest.

Who Can Join the Study?

  • The patient must be a child between 3 months and 2 years old.
  • The child must be staying in a special hospital unit for children after heart surgery, known as a paediatric cardiac surgical intensive care unit.
  • The child must have been treated for a congenital heart disease, which is a heart condition that a baby is born with.
  • The specific heart conditions included are ventricular septal defect (VSD), which is a hole between the lower chambers of the heart; atrial septal defect (ASD), which is a hole between the upper chambers of the heart; pulmonary stenosis, which is a narrowing of the valve that lets blood flow to the lungs; or tetralogy of Fallot, which is a combination of four different heart defects.
  • The surgery must involve a sternotomy, which means the surgeon makes an opening through the breastbone to reach the heart.
  • The surgery must use intraoperative cardiopulmonary bypass, which is a machine that takes over the job of the heart and lungs during the operation.
  • The child must have received cefazolin, which is an antibiotic prophylaxis, meaning a medicine given before surgery to prevent an infection.
  • The patient must have social security coverage, which is a form of health insurance.
  • The legal guardians, or the people legally responsible for the child, must understand the study information and sign a consent form to agree to participate.

Who Cannot Join the Study?

  • You are scheduled for emergency cardiac surgery, which means a heart operation that must be done immediately due to a life-threatening situation.
  • A relative of yours is the investigator, which is the doctor or researcher in charge of enrolling people into this study.
  • You have a history of cardiac or thoracic surgery, meaning you have had operations on your heart or the chest area in the past.
  • You have haemostasis disorders, which are conditions that prevent your blood from clotting properly to stop bleeding.
  • You have immunodeficiency, which means your body’s immune system (the system that fights germs) is not working correctly.
  • You have bacterial colonization, which means germs are living in your body, and you are being given a type of preventative medicine other than cefazolin.
  • You have hypersensitivity, which is an allergic reaction, to the medicine being studied, or to cephalosporin or penicillin antibiotics.
  • You are already participating in another interventional study, which is a clinical trial where researchers give a specific treatment to see how it works.
  • You have already joined this specific study.
  • You have a medical reason why you cannot undergo microdialysis (a method used to measure medicine levels in body fluids) or surgery.
  • You are taking another medicine that might interfere with how cefazolin works, or you have taken cefazolin in the last 7 days.

Where you can join this trial?

Verified and Recommended Sites

No sites found in this category

Verified Sites

No sites found in this category

Other Sites

Site Name City Country Status
Hopital Beaujon Clichy France

Want to learn more about this study or check if you can participate? Contact us.

Trial status

Country Status Recruitment Start
France France
Not yet recruiting
02.03.2026

Trial locations

Investigated drugs:

Cefazolin is an antibiotic medication given through a vein to help fight and prevent bacterial infections.

Mediastinitis – This is an inflammation or infection located in the mediastinum, which is the area in the middle of the chest between the lungs. It often develops following surgery or other invasive procedures in the chest area. The condition typically begins when bacteria enter this space and begin to multiply. As it progresses, the inflammation can spread to nearby tissues and organs within the chest cavity. It is characterized by an increase in inflammatory markers in the body.

Trial ID:
2025-521988-13-00
Protocol code:
APHP241591
NCT ID:
NCT07327502
Trial Phase:
Therapeutic confirmatory (Phase III)

Other Trials to Consider

  • Study on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study of cefuroxime and metronidazole to prevent infections after Whipple’s procedure in patients with high risk of bile contamination

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands